StockData
Obsidian Therapeutics, Inc. logo

Obsidian Therapeutics, Inc. (OBX) stock

OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)

Close on Nov 20, 2026Market cap $741.28MP/E –Yield –

Obsidian Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Obsidian Therapeutics

Obsidian Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Obsidian Therapeutics figures

See a number that looks wrong?